paroxetine has been researched along with 3-n-(2-fluoroethyl)spiperone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artigas, F; Colombo, C; Fazio, F; Gobbo, C; Messa, C; Moresco, R; Smeraldi, E; Zanardi, R | 1 |
| Artigas, F; Colombo, C; Fazio, F; Galli, L; Gilardi, MC; Gobbo, C; Lucignani, G; Messa, C; Moresco, RM; Rizzo, G; Smeraldi, E; Zanardi, R | 1 |
2 other study(ies) available for paroxetine and 3-n-(2-fluoroethyl)spiperone
| Article | Year |
|---|---|
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.
Topics: Adult; Depression; Female; Fluorine Radioisotopes; Humans; Male; Paroxetine; Prefrontal Cortex; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Spiperone; Tomography, Emission-Computed; Treatment Outcome | 2001 |
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Case-Control Studies; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluorine Radioisotopes; Humans; Ligands; Male; Middle Aged; Paroxetine; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Spiperone; Tomography, Emission-Computed | 2003 |